1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Postoperative Pain Therapeutics Market

4. Market Overview
      4.1. Introduction
            4.1.1. Definition
            4.1.2. Industry Evolution / Developments
      4.2. Overview
      4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
      4.4. Global Postoperative Pain Therapeutics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
      5.1. Regulatory Scenario Assessment
      5.2. Overview of Total Surgical Procedures Requiring Postoperative Pain Management
      5.3. Pipeline Analysis
      5.4. Healthcare industry Overview

6. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Drug Class 
      6.1. Introduction & Definition
      6.2. Key Findings / Developments
      6.3. Market Value Forecast, by Drug Class, 2017–2027
            6.3.1. Opioids
            6.3.2. NSAIDS
            6.3.3. Tricyclic Antidepressants
            6.3.4. Antiepileptic Drugs
            6.3.5. Local Anesthetics
            6.3.6. Others
      6.4. Market Attractiveness, by Drug Class 

7. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Mode of Administration 
      7.1. Introduction & Definition
      7.2. Key Findings / Developments
      7.3. Market Value Forecast, by Mode of Administration, 2017–2027
            7.3.1. Oral
            7.3.2. Intravenous
            7.3.3. Intramuscular
            7.3.4. Others
      7.4. Market Attractiveness, by Mode of Administration 

8. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Distribution Channel 
      8.1. Introduction & Definition
      8.2. Key Findings / Developments
      8.3. Market Value Forecast, by Distribution Channel, 2017–2027
            8.3.1. Hospital Pharmacies
            8.3.2. Retail Pharmacies
            8.3.3. Online Pharmacies 
            8.3.4. Others
      8.4. Market Attractiveness, by Distribution Channel 

9. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Region
      9.1. Key Findings
      9.2. Market Value Forecast, by Region
            9.2.1. North America 
            9.2.2. Europe 
            9.2.3. Asia Pacific 
            9.2.4. Latin America 
            9.2.5. Middle East & Africa 
      9.3. Market Attractiveness, by Country/Region

10. North America Postoperative Pain Therapeutics Market Analysis and Forecast
      10.1. Introduction
            10.1.1. Key Findings
      10.2. Market Value Forecast, by Drug Class, 2017–2027
            10.2.1. Opioids
            10.2.2. NSAIDS
            10.2.3. Tricyclic Antidepressants
            10.2.4. Antiepileptic Drugs
            10.2.5. Local Anesthetics
            10.2.6. Others
      10.3. Market Value Forecast, by Mode of Administration, 2017–2027
            10.3.1. Oral
            10.3.2. Intravenous
            10.3.3. Intramuscular
            10.3.4. Others
      10.4. Market Value Forecast, by Distribution Channel, 2017–2027
            10.4.1. Hospital Pharmacies
            10.4.2. Retail Pharmacies
            10.4.3. Online Pharmacies 
            10.4.4. Others
      10.5. Market Value Forecast, by Country, 2017–2027
            10.5.1. U.S.
            10.5.2. Canada
      10.6. Market Attractiveness Analysis 
            10.6.1. By Drug Class 
            10.6.2. By Mode of Administration 
            10.6.3. By Distribution Channel 
            10.6.4. By Country

11. Europe Postoperative Pain Therapeutics Market Analysis and Forecast
      11.1. Introduction
            11.1.1. Key Findings
      11.2. Market Value Forecast, by Drug Class, 2017–2027
            11.2.1. Opioids
            11.2.2. NSAIDS
            11.2.3. Tricyclic Antidepressants
            11.2.4. Antiepileptic Drugs
            11.2.5. Local Anesthetics
            11.2.6. Others
      11.3. Market Value Forecast, by Mode of Administration, 2017–2027
            11.3.1. Oral
            11.3.2. Intravenous
            11.3.3. Intramuscular
            11.3.4. Others
      11.4. Market Value Forecast, by Distribution Channel, 2017–2027
            11.4.1. Hospital Pharmacies
            11.4.2. Retail Pharmacies
            11.4.3. Online Pharmacies 
            11.4.4. Others
      11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
      11.6. Market Attractiveness Analysis 
            11.6.1. By Drug Class 
            11.6.2. By Mode of Administration 
            11.6.3. By Distribution Channel 
            11.6.4. By Country/Sub-region

12. Asia Pacific Postoperative Pain Therapeutics Market Analysis and Forecast
      12.1. Introduction
            12.1.1. Key Findings
      12.2. Market Value Forecast, by Drug Class, 2017–2027
            12.2.1. Opioids
            12.2.2. NSAIDS
            12.2.3. Tricyclic Antidepressants
            12.2.4. Antiepileptic Drugs
            12.2.5. Local Anesthetics
            12.2.6. Others
      12.3. Market Value Forecast, by Mode of Administration, 2017–2027
            12.3.1. Oral
            12.3.2. Intravenous
            12.3.3. Intramuscular
            12.3.4. Others
      12.4. Market Value Forecast, by Distribution Channel, 2017–2027
            12.4.1. Hospital Pharmacies
            12.4.2. Retail Pharmacies
            12.4.3. Online Pharmacies 
            12.4.4. Others
      12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
      12.6. Market Attractiveness Analysis 
            12.6.1. By Drug Class 
            12.6.2. By Mode of Administration 
            12.6.3. By Distribution Channel 
            12.6.4. By Country/Sub-region

13. Latin America Postoperative Pain Therapeutics Market Analysis and Forecast
      13.1. Introduction
            13.1.1. Key Findings
      13.2. Market Value Forecast, by Drug Class, 2017–2027
            13.2.1. Opioids
            13.2.2. NSAIDS
            13.2.3. Tricyclic Antidepressants
            13.2.4. Antiepileptic Drugs
            13.2.5. Local Anesthetics
            13.2.6. Others
      13.3. Market Value Forecast, by Mode of Administration, 2017–2027
            13.3.1. Oral
            13.3.2. Intravenous
            13.3.3. Intramuscular
            13.3.4. Others
      13.4. Market Value Forecast, by Distribution Channel, 2017–2027
            13.4.1. Hospital Pharmacies
            13.4.2. Retail Pharmacies
            13.4.3. Online Pharmacies 
            13.4.4. Others
      13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
      13.6. Market Attractiveness Analysis 
            13.6.1. By Drug Class 
            13.6.2. By Mode of Administration 
            13.6.3. By Distribution Channel 
            13.6.4. By Country/Sub-region

14. Middle East & Africa Postoperative Pain Therapeutics Market Analysis and Forecast
      14.1. Introduction
            14.1.1. Key Findings
      14.2. Market Value Forecast, by Drug Class, 2017–2027
            14.2.1. Opioids
            14.2.2. NSAIDS
            14.2.3. Tricyclic Antidepressants
            14.2.4. Antiepileptic Drugs
            14.2.5. Local Anesthetics
            14.2.6. Others
      14.3. Market Value Forecast, by Mode of Administration, 2017–2027
            14.3.1. Oral
            14.3.2. Intravenous
            14.3.3. Intramuscular
            14.3.4. Others
      14.4. Market Value Forecast, by Distribution Channel, 2017–2027
            14.4.1. Hospital Pharmacies
            14.4.2. Retail Pharmacies
            14.4.3. Online Pharmacies 
            14.4.4. Others
      14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Rest of Middle East & Africa
      14.6. Market Attractiveness Analysis 
            14.6.1. By Drug Class 
            14.6.2. By Mode of Administration 
            14.6.3. By Distribution Channel 
            14.6.4. By Country/Sub-region

15. Company Profiles
      15.1. Mallinckrodt Pharmaceuticals
      15.2. Pacira BioSciences, Inc.
      15.3. Trevena, Inc.
      15.4. Heron Therapeutics
      15.5. Pfizer, Inc.
      15.6. Teva Pharmaceutical Industries Ltd.
      15.7. Novartis AG
      15.8. Camarus
      15.9. Eli Lilly & Company
      15.10. Mallinckrodt Pharmaceuticals
      15.11. Bayer AG
      15.12. Others

List of Tables:

Table 01: Incidence (%) of Chronic Postoperative Pain
Table 02: Pipeline Analysis
Table 03: Principle difference between U.S., EU, and India 
Table 04: Regulatory Scenario Assessment - Administrative Requirements 
Table 05: Global Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 06: Global Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 07: Global Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 08: Global Postoperative Pain Therapeutics Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 10: North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 11: North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 12: North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 13: Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 14: Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 15: Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 18: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 19: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 22: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 23: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 24: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 26: Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 27: Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 28: Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures:

Figure 01: Global Postoperative Pain Therapeutics Market Snapshot
Figure 02: Regulatory Approval Process - U.S.
Figure 03: Regulatory Approval Process - Europe
Figure 04: Regulatory Approval Process - India
Figure 05: Total Surgical Procedures requiring Postoperative Pain Management
Figure 06: Global Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 07: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Opioids, 2017–2027
Figure 08: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by NSAIDS, 2017–2027
Figure 09: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Local Anesthetics, 2017–2027
Figure 10: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Tricyclic Antidepressants, 2017–2027
Figure 11: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Antiepileptic Drugs, 2017–2027
Figure 12: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 13: Global Postoperative Pain Therapeutics Market Attractiveness, by Drug Class, 2019 - 2027
Figure 14: Global Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 15: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral, 2017–2027
Figure 16: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intramuscular, 2017–2027
Figure 17: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intravenous, 2017–2027
Figure 18: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 19: Global Postoperative Pain Therapeutics Market Attractiveness, by Route of Administration, 2019 - 2027
Figure 20: Global Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 21: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027
Figure 22: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027
Figure 23: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027
Figure 24: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 25: Global Postoperative Pain Therapeutics Market Attractiveness, by Distribution Channel, 2019?2027
Figure 26: Global Postoperative Pain Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Region 2017–2027
Figure 27: Global Postoperative Pain Therapeutics Market Value Share Analysis, by Region, 2018 and 2027
Figure 28: Global Postoperative Pain Therapeutics Market Attractiveness, by Region, 2019–2027
Figure 29: North America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 30: North America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country, 2017–2025
Figure 31: North America Postoperative Pain Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
Figure 32: North America Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 33: North America Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 34: North America Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 35: North America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 36: North America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 37: Europe Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 38: Europe Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 39: Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 40: Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 41: Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42: Europe Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 43: Europe Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 44: Europe Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 45: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 46: Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 47: Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 48: Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 49: Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 50: Asia Pacific Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 51: Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 52: Asia Pacific Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 53: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 54: Latin America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 55: Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 56: Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 57: Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 58: Latin America Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 59: Latin America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 60: Latin America Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 61: Middle East & Africa Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 62: Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 63: Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 64: Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 65: Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 66: Middle East & Africa Postoperative Pain Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 67: Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 68: Middle East & Africa Postoperative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019–2027
Figure 69: Mallinckrodt Pharmaceuticals, Breakdown of Net Sales, by Business Segment, 2016
Figure 70: Mallinckrodt Pharmaceuticals, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 71: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 72: Pfizer, Inc., Breakdown of Net Sales, by Region, 2018
Figure 73: Pfizer, Inc., Breakdown of Net Sales, by Business Segment (%), 2018
Figure 74: Pfizer, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 75: Novartis AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 76: Novartis AG, Breakdown of Net Sales (%), of Business Segment, by Region/Country, 2018
Figure 77: Novartis AG, Revenue Breakdown of Net Sales (%), by Total Innovative Medicine Segment, 2018
Figure 78: Novartis, AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 79: Eli Lilly and Company, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 80: Eli Lilly and Company, Breakdown of Net Sales (%), by Region, 2017
Figure 81: Eli Lilly and Company, Breakdown of Net Sales (%), by Business Segment, 2017
Figure 82: Eli Lilly and Company, Research & Development Cost (US$ Mn), 2016 and 2017
Figure 83: Teva Pharmaceutical Industries Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 84: Teva Pharmaceutical Industries Ltd., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 85: Teva Pharmaceutical Industries Ltd., Breakdown of Net Sales, by Region, 2017
Figure 86: Teva Pharmaceutical Industries Ltd., Breakdown of Net Sales, by Operating Segment, 2017
Figure 87: Camurus AB, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 88: Camurus AB, Breakdown of Net Sales, by Region, 2017
Figure 89: Camurus AB, Breakdown of Net Sales, by Business Segment, 2017
Figure 90: Camurus AB, Research & Development Cost (US$ Mn), 2016–2017
Figure 91: Bayer AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018 Figure 92: Bayer AG, Breakdown of Net Sales (%), by Region/Country, 2018
Figure 93: Bayer AG, Revenue Breakdown of Net Sales (%), by Business segment, 2018
Figure 94: Bayer AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 95: Pacira BioSciences, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 96: Pacira BioSciences, Inc., Breakdown of Net Sales (%), by Product, 2018
Figure 97: Pacira BioSciences, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 98: Trevena, Inc., Revenue (US$ Mn, 2015, 2016, 2018)
Figure 99: Trevena, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 100: Heron Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 101: Heron Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Postoperative Pain Therapeutics Market

Buy Now